Administration of 24-h Intravenous Infusions of Trabectedin in Ambulatory Patients with Mesenchymal Tumors via Disposable Elastomeric Pumps: An Effective and Patient-Friendly Palliative Treatment OptionPatrick Schöffski, Marguerite Stas, Ignace Samson et al.|Onkologie|2012Cited by 18
9425 Administration of 24-hour intravenous infusions of trabectedin (Yondelis®) every 3 weeks in ambulatory patients with mesenchymal tumors via the disposable elastomeric pump Baxter LV10: a feasible, convenient, effective and patient-friendly palliative treatment optionPatrick Schöffski, A.T. van Oosterom, Linda Cerbone et al.|European Journal of Cancer Supplements|2009Cited by 1